In a considerable percentage of the hearing-impaired population, the benefits of conventional amplification may be limited by acoustic feedback, occlusion effect, and/or ear discomfort. Implantable and semi-implantable hearing devices (IHDs) have been developed as an option for patients who derive limited benefit from traditional HAs, but who are not yet candidates for cochlear implants. The Ototronix MAXUM System (Ototronix LLC, Houston, TX) is a semi-implantable device that amplifies sounds using electromagnetic energy transferred from an external ear canal mold to an internal surgically implanted magnet (Fig. 6.1).
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Baker RS, Wood MW, Hough JV. The implantable hearing device for sensorineural hearing impairment. The hough ear institute experience. Otolaryngol clin N Am. 1995;28:147–53.Google Scholar
Hough JV, Dyer Jr RK, Matthews P, Wood MW. Early clinical results: SOUNDTEC implantable hearing device phase II study. Laryngoscope. 2001;111:1–8.PubMedCrossRefGoogle Scholar
Hough JV, Matthews P, Wood MW, Dyer Jr RK. Middle ear electromagnetic semi-implantable hearing device: results of the phase II SOUNDTEC direct system clinical trial. Otol Neurotol. 2002;23:895–903.PubMedCrossRefGoogle Scholar
Roland PS, Shoup AG, Shea MC, Richey HS, Jones DB. Verification of improved patient outcomes with a partially implantable hearing aid, The SOUNDTEC direct hearing system. Laryngoscope. 2001;111:1682–6.PubMedCrossRefGoogle Scholar